Prevalence and prognosis of asymptomatic left ventricular diastolic dysfunction in ambulatory patients with coronary

Xiushui Ren1, Bryan Ristow, Beeya Na

  • 1Department of Cardiology, California Pacific Medical Center, University of California, San Francisco, USA. xiushui@yahoo.com

Insights

Asymptomatic moderate to severe left ventricular (LV) diastolic dysfunction in coronary heart disease (CHD) patients predicts heart failure (HF) hospitalization and heart disease death. Aggressive therapy may benefit these patients.

Area of Science:

  • Cardiology
  • Cardiovascular Medicine
  • Diagnostic Imaging

Background:

  • Left ventricular (LV) diastolic dysfunction is a known predictor of adverse cardiovascular outcomes.
  • The prevalence and prognostic significance of asymptomatic LV diastolic dysfunction in coronary heart disease (CHD) patients without a history of heart failure (HF) remain unclear.

Purpose of the Study:

  • To investigate the association between asymptomatic LV diastolic dysfunction and cardiovascular outcomes in ambulatory patients with stable CHD and preserved systolic function.

Main Methods:

  • Echocardiography was employed to assess LV diastolic function in 693 patients with stable CHD, normal LV ejection fraction (> or =50%), and no prior HF history.
  • Cox proportional hazards models were utilized to analyze the association of LV diastolic dysfunction with cardiovascular events over a 3-year follow-up period.

Main Results:

  • Moderate to severe LV diastolic dysfunction was identified in 10% of the study cohort (72 out of 693 patients).
  • After multivariable adjustment, moderate to severe LV diastolic dysfunction significantly predicted incident hospitalization for HF (HR 6.3) and death from heart disease (HR 3.9).

Conclusions:

  • Moderate to severe asymptomatic LV diastolic dysfunction is prevalent in patients with stable CHD and normal systolic function.
  • This condition serves as a strong predictor of future HF hospitalizations and cardiac mortality.
  • Patients identified with asymptomatic LV diastolic dysfunction may warrant more intensive therapeutic strategies to prevent or postpone HF development.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...